The number of PD-L1+CTCs from different patients within the same study also vary dramatically, ranging from one cell to hundreds of CTCs in blood samples from prostate cancer patients, or from one cell to 20 in patients with colorectal cancer [84,85,88]. This evidence concerns the gene CD274 and prostate carcinoma.